Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-006317

General Counsel sold 1,376 shares at $3.34 ($4,593)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Sale : show line 1 in the form −1,376 $3.34 $4,593 682,000 D
Open-market sales · 1,376 sh · avg $3.34 · $4,593
Loading xslF345X05/form4.xml…